Foghorn Therapeutics competitorsClear all

Foghorn Therapeutics's top competitors include Nurix, Kymera Therapeutics, Arvinas and Ultivue.
Foghorn Therapeutics
Foghorn Therapeutics
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
Nurix
Nurix
Nurix, Inc. is a leader in discovering and developing a new class of drugs that work by modulating the protein regulation machinery of the cell.
Kymera Therapeutics
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
Arvinas
Arvinas
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
Ultivue
Ultivue
Ultivue operates in the biotechnology industry.
Founding Date
Founding Date
2016
Founding Date
2009
Founding Date
2017
Founding Date
N/A
Founding Date
2015
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Locations
San Francisco, US HQ
Locations
Cambridge, US HQ
Locations
New Haven, US HQ
Locations
Cambridge, US HQ
Segrate, IT
Employees
Employees
85
Employees
1251% increase
Employees
685% increase
Employees
13329% increase
Employees
609% increase
Valuation ($)
Valuation ($)
707.5 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
947.2 m
Valuation ($)
N/A
Twitter followers
Twitter followers
507
Twitter followers
N/A
Twitter followers
1.7 k
Twitter followers
1.6 k
Twitter followers
275
Number of tweets (last 30 days)
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
13
Number of tweets (last 30 days)
20
Number of tweets (last 30 days)
2
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
7.9
Average likes per tweet (last 30 days)
3.6
Average likes per tweet (last 30 days)
2
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
92.31%
Percentage of tweets with engagement (last 30 days)
90%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
320003
Alexa Website Rank
414673
Alexa Website Rank
400507
Alexa Website Rank
332663
Alexa Website Rank
420838
Employee Rating
Employee Rating
N/A
Employee Rating
3.8
Employee Rating
N/A
Employee Rating
5
Employee Rating
3.5

Financial

Net income
Net income
($51.1m) (FY, 2019)
Net income
N/A
Net income
N/A
Net income
($70.3m) (FY, 2019)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 120m (9 months ago)
Latest funding round
$ 102m (9 months ago)
Latest funding round
N/A
Latest funding round
$ 22m (over 1 year ago)
Total funding raised
Total funding raised
$ 50m
Total funding raised
$ 165.2m
Total funding raised
$ 197m
Total funding raised
$ 111.6m
Total funding raised
$ 57.3m
For sources of this data, please see the company profile

View company profiles

Nurix
HQ
San Francisco, US
Employees
125↑ 1% increase

Nurix, Inc. is a leader in discovering and developing a new class of drugs that work by modulating the protein regulation machinery of the cell.

View company
Kymera Therapeutics
HQ
Cambridge, US
Employees
68↑ 5% increase

Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.

View company
Arvinas
HQ
New Haven, US
Employees
133↑ 29% increase

Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.

View company
Ultivue
HQ
Cambridge, US
Employees
60↑ 9% increase

Ultivue operates in the biotechnology industry.

View company